• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌诊断时分期相关的预防性细胞学检查:丹麦420名女性的研究

Prophylactic cytological investigation for cervical cancer in relation to stage at diagnosis: a study of 420 women in Denmark.

作者信息

Olesen F

出版信息

J R Coll Gen Pract. 1988 Aug;38(313):356-9.

PMID:3256647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1711521/
Abstract

Despite widespread cervical smear testing 500-600 cases of cancer of the cervix are still diagnosed each year in Denmark, with over 200 deaths. The distribution of the different stages of cancer among 420 women who were diagnosed during 1983 was correlated with the number of previous cervical smears, whether done purely for screening reasons or for minor gynaecological problems. Of the women with cancer 56% had never been screened, and among these 42% were diagnosed at stage 1; 19% had been screened once; 61% of them at stage 1. The remainder (25%) had been screened at least twice, and 81% of them were diagnosed at stage 1. Among the patients who had been screened at least twice, with the last screening not more than three or five years ago, about 90% were diagnosed at stage 1 and the rest at stage 2.The introduction of cervical smear testing will thus mean a considerably better stage distribution among cases which develop invasive cancer of the cervix, and both case fatality and mortality rates will be reduced by organized programmes, which have better participation rates than disorganized use of cervical smears.

摘要

尽管丹麦广泛开展了宫颈涂片检查,但每年仍有500 - 600例宫颈癌被确诊,其中超过200人死亡。对1983年确诊的420名女性患者不同癌症阶段的分布情况,与之前宫颈涂片检查的次数进行了关联分析,这些检查是单纯出于筛查目的,还是因轻微妇科问题而进行的。患有癌症的女性中,56%从未接受过筛查,其中42%在1期被诊断出癌症;19%接受过一次筛查,其中61%在1期被诊断出癌症。其余(25%)至少接受过两次筛查,其中81%在1期被诊断出癌症。在至少接受过两次筛查且最后一次筛查不超过三或五年前的患者中,约90%在1期被诊断出癌症,其余在2期。因此,宫颈涂片检查的引入将意味着在发生宫颈浸润癌的病例中,病例分期分布会显著改善,通过有组织的项目,病例死亡率和死亡率都将降低,这些项目的参与率比无组织地使用宫颈涂片更高。

相似文献

1
Prophylactic cytological investigation for cervical cancer in relation to stage at diagnosis: a study of 420 women in Denmark.宫颈癌诊断时分期相关的预防性细胞学检查:丹麦420名女性的研究
J R Coll Gen Pract. 1988 Aug;38(313):356-9.
2
Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols.宫颈癌患者的巴氏涂片检查史:筛查方案评估
Obstet Gynecol. 1987 Feb;69(2):151-5.
3
Review of the screening history of Alberta women with invasive cervical cancer.对艾伯塔省浸润性宫颈癌女性筛查史的回顾。
CMAJ. 1997 Sep 1;157(5):513-9.
4
Optimal frequency of screening for cervical cancer: a Toronto case-control study.
IARC Sci Publ. 1986(76):125-31.
5
Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.1966年至1982年丹麦玛丽博县涂片检查结果为阴性后的宫颈癌风险
IARC Sci Publ. 1986(76):69-86.
6
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
7
[Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].[2006年在法国诊断出的浸润性宫颈癌病例的细胞学病史]
Gynecol Obstet Fertil. 2007 Sep;35(9):764-71. doi: 10.1016/j.gyobfe.2007.07.019. Epub 2007 Aug 30.
8
[Are analyses of cytological cervix smears from young women more harmful than beneficial?].[对年轻女性宫颈细胞学涂片的分析是否弊大于利?]
Tidsskr Nor Laegeforen. 2007 Jun 28;127(13):1782-5.
9
[Screening profile of women who have died from cervical cancer].
Ugeskr Laeger. 2008 Feb 25;170(9):727-30.
10
Recommendations for cervical screening 1997. Members of the Working Party on Cervical Screening.
N Z Med J. 1998 Mar 27;111(1062):94-8.

引用本文的文献

1
A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.美国机会性筛查中发生的宫颈癌的全州人群为基础的评估。
Gynecol Oncol. 2020 Nov;159(2):344-353. doi: 10.1016/j.ygyno.2020.08.033. Epub 2020 Sep 22.

本文引用的文献

1
The cytologic history of 245 patients developing invasive cervical carcinoma.245例浸润性宫颈癌患者的细胞学病史。
Am J Obstet Gynecol. 1984 Mar 1;148(5):685-90. doi: 10.1016/0002-9378(84)90774-9.
2
[Geographical differences in cervix cytology screening and the incidence of cervix cancer 1943-1982].[1943 - 1982年子宫颈细胞学筛查的地理差异与子宫颈癌发病率]
Ugeskr Laeger. 1984 Nov 5;146(45):3477-82.
3
Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire.约克郡500名浸润性宫颈癌女性的宫颈涂片检查史。
Br Med J (Clin Res Ed). 1984 Oct 6;289(6449):896-8. doi: 10.1136/bmj.289.6449.896.
4
Case-control studies for the evaluation of screening.用于评估筛查的病例对照研究。
J Chronic Dis. 1986;39(5):399-405. doi: 10.1016/0021-9681(86)90126-8.
5
Use of Pap smear in general practice by case finding or screening programme.通过病例发现或筛查计划在全科医疗中使用巴氏涂片检查。
Scand J Prim Health Care. 1986 Feb;4(1):59-62. doi: 10.3109/02813438609013973.
6
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.北欧国家宫颈癌死亡率趋势:与有组织的筛查计划的关联。
Lancet. 1987 May 30;1(8544):1247-9. doi: 10.1016/s0140-6736(87)92695-x.